Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07080606 · ClinicalTrials.gov registry record · NA
Brief Exposure and Exercise for PTSD.
A NA study of PTSD - Post Traumatic Stress Disorder, sponsored by Troy Hubert.
- Recruiting
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT07080606: Recruiting NA study of PTSD - Post Traumatic Stress Disorder, sponsored by Troy Hubert.
NCT07080606 is a NA study of PTSD - Post Traumatic Stress Disorder that is actively recruiting participants, run by Troy Hubert. The registered enrollment target is 6 participants, below the 279-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07080606, a NA study of PTSD - Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Troy Hubert.
- RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if 8 sessions of brief exposure and exercise therapy works to treat Post Traumatic Stress Disorder (PTSD) in adults. This study will also learn if participants think brief exposure and exercise therapy is a good and doable treatment. and The main questions it aims to answer are: * Do participants find brief exposure and exercise an acceptable and feasible means of treatment for PTSD? * Does brief exposure and exercise decreases of the severity of PTSD symptoms? Participants will: * Complete weekly questionnaires for 10-14 weeks. * Attend 8 twice weekly exposure therapy and exercise sessions for 4 weeks.
Primary Outcome
The PCL-5 is a 20-item self-report questionnaire used to assess PTSD symptom severity. Each of the 20 PCL-5 items corresponds to symptoms of PTSD in the DSM-5. Items are rated on a Likert scale from 0 (not at all) to 4 (extremely) based upon how bothered participants are by each symptom. Items on the PCL-5 are summed, resulting in a total score of PTSD symptom severity from 0-80. Scores \>30 indicate probable PTSD.
Conditions Studied
Interventions
- BEHAVIORAL Brief exposure therapy and exercise
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT07080606 shows while recruiting
NCT07080606 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 279-participant average among 14 other PTSD - Post Traumatic Stress Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with PTSD - Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Brief exposure therapy and exercise is the first listed.
NCT07080606 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT07080606 about?
NCT07080606 is a clinical study titled "Brief Exposure and Exercise for PTSD.". The goal of this clinical trial is to learn if 8 sessions of brief exposure and exercise therapy works to treat Post Traumatic Stress Disorder (PTSD) in adults. This study will also learn if participants think brief exposure and exercise therapy is a good and doable treatment. and The main questions...
What is the current status of trial NCT07080606?
This trial is currently recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2025-06-25. Estimated completion is 2026-03-30.
What conditions does trial NCT07080606 study?
This clinical trial studies the following conditions: PTSD - Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT07080606?
The interventions under investigation include: Brief exposure therapy and exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07080606?
This trial is sponsored by Troy Hubert, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07080606 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD - Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07080606's enrollment target sits among peer trials
6 15th of 14 the lowest of 14 other PTSD - Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD - Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment for PTSD and Tinnitus
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Diet and Microbiome Interactions: Application in Posttraumatic Stress Disorder in Adults Consuming Vegetable Drinks
RECRUITING · NA
-
Transcranial Magnetic Stimulation in Veterans With PTSD
RECRUITING · NA
-
Empowering Perinatal Adolescents Through Writing
RECRUITING · NA
-
Restorative Early Sleep Treatment After the Emergency Department
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI